Arshad Mohammad Khanani MD

Retinal Disease

Physician

950 Ryland StReno, NV 89502
Phone+1 775-329-0286
Fax+1 775-329-4243

Dr. Khanani is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khanani's full profile Already have an account?

Education & Training

Texas Tech University Health Sciences Center at LubbockResidency, Ophthalmology, 2005 - 2008
Baylor College of MedicineInternship, Internal Medicine, 2004 - 2005
Texas Tech University Health Sciences Center School of MedicineClass of 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NV State Medical License 2010 - 2027
TX State Medical License 2007 - 2012
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Ocriplasmin Research to Better Inform Treatment (ORBIT)
COMPLETED
A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA
COMPLETED
Cooling Anesthesia for Intravitreal Injection Start of enrollment: 2018 Nov 30
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

Imaging Biomarkers in the Management of Retinal Diseases: Clinical Applications and Future Directions.
Hannah Khan, Dhruv P Patel, Seenu M Hariprasad, Arshad M Khanani, Aamir A Aziz
Ophthalmic Surgery, Lasers & Imaging Retina. 2026-08-17
Safety and efficacy of topical OCS-01 ophthalmic suspension for the treatment of diabetic macular oedema: stage 1 of a multicentre, double-blind, randomised, vehicle-c...
Arshad M Khanani, Ramin Tadayoni, Sabri Markabi, Sunil Patel, Hani Salehi-Had
Eclinicalmedicine. 2026-08-01
Pooled Analyses of Anatomic and Visual Function Data of Revakinagene Taroretcel-lwey in Participants with Macular Telangiectasia Type 2.
Roger A Goldberg, Debora C Manning, Joanna Yankey, W Lloyd Clark, Muna I Bitar
Ophthalmology. Retina. 2026-07-20

Journal Articles

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
Arshad M Khanani, Sunil S Patel, JAMA Ophthalmology

Authored Content

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020

Press Mentions

Astellas Announces New Data Demonstrating Long-Term Efficacy of Izervay in Slowing GA ProgressionOctober 20th, 2025
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025October 14th, 2025
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical AdvisorsAugust 25th, 2025